Mercury Laboratories Limited
Indian Pharmaceutical Exporter ยท Gastrointestinal Specialist ยท $394.7K Total Trade ยท DGFT Verified
Mercury Laboratories Limited is an Indian pharmaceutical exporter with a total trade value of $394.7K across 2 products in 2 therapeutic categories. Based on 16 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Lactulose ($321.4K), Roxithromycin ($73.2K), .
Mercury Laboratories Limited โ Export Portfolio & Destination Treemap

Who is Mercury Laboratories Limited? โ Company Overview & Market Position
Mercury Laboratories Limited, established in 1962, is a prominent Indian pharmaceutical company headquartered in Vadodara, Gujarat. The company specializes in the manufacturing, marketing, and export of a diverse range of pharmaceutical formulations, with a strong emphasis on mother and child healthcare. Its product portfolio includes tablets, oral liquids, injections, small volume parenterals, and ophthalmic preparations.
Incorporated as a public limited company on February 12, 1982, under the Corporate Identification Number (CIN) L74239MH1982PLC026341, Mercury Laboratories Limited has demonstrated consistent growth and innovation in the pharmaceutical sector. The company is listed on the Bombay Stock Exchange (BSE) under the ticker symbol 538964. As of March 11, 2026, the stock price was โน780.00, reflecting a 1.04% increase from the previous close.
Mercury Laboratories Limited operates with an authorized capital of โน25 million and a paid-up capital of โน12 million. The company employs approximately 503 individuals, underscoring its significant presence in the pharmaceutical manufacturing industry. For more information, visit their official website at www.mercurylabs.com.